NEW CLINICAL TRIALS AVAILABLE FOR MPN PATIENTS

  • MPNRF | April 6, 2021

    Two new clinical trials available for MPN patients

    Click here to learn more about current clinical trials for PV, ET, and MF patients.

    Vactosertib

    This is a 2-tiered, Phase 2, Rule-based, Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib (TEW-7197) in the Treatment of Anemic  Patients With Philadelphia Chromosome-negative MPNs (Ph-neg MPNs). Read the full description here

    Status: Not yet recruiting

    PRT543

     This is a Phase 1 cohort, dose-escalation study of PRT543 inpatients with advanced cancers who have exhausted available treatment options. The purpose of this study is to define a safe dose andschedule to be used in the      development of PRT543.

       Read the full
       description here

       Status: Recruiting